Higher-risk myelodysplastic syndromes with del(5q): does the del(5q) matter?

Gorshein, E; Weber, UM; Gore, S

Gore, S (corresponding author), Yale Sch Med, Div Hematol, New Haven, CT 06520 USA.

EXPERT REVIEW OF HEMATOLOGY, 2020; 13 (3): 233

Abstract

Introduction: Myelodysplastic Syndrome (MDS) represents a group of cancers characterized by abnormal blood cell formation and maturation, leading to v......

Full Text Link